Rapidly developed BRAF inhibitor-induced verrucous keratosis

J Dermatol. 2017 Nov;44(11):e274-e275. doi: 10.1111/1346-8138.13962. Epub 2017 Jul 22.

Authors

Yoshio Nakamura^{1

2}, Taisuke Mori³, Yujiro Takae⁴, Arata Tsutsumida¹, Akira Takahashi¹, Kenjiro Namikawa¹, Ikuko Hirai^{2

4}, Naoya Yamazaki¹

Affiliations

¹ Department of Dermatological Oncology, National Cancer Center Hospital, Tokyo, Japan.
² Department of Dermatology, Keio University, Tokyo, Japan.
³ Department of Pathology, National Cancer Center Hospital, Tokyo, Japan.
⁴ Department of Dermatology, Saiseikai Yokohama City South Hospital, Kanagawa, Japan.

PMID: 28734005
DOI: 10.1111/1346-8138.13962

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Antineoplastic Agents / adverse effects*
Female
Humans
Keratosis / chemically induced*
Keratosis / pathology
Melanoma / genetics
Proto-Oncogene Proteins B-raf / antagonists & inhibitors*
Proto-Oncogene Proteins B-raf / genetics
Skin / pathology
Skin Neoplasms / genetics

Substances

Antineoplastic Agents
BRAF protein, human
Proto-Oncogene Proteins B-raf